Seven Eight Capital, LP Iovance Biotherapeutics, Inc. Transaction History

Seven Eight Capital, LP

$1.05 Billion
Q3 2024

A detailed history of Seven Eight Capital, LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 57,188 shares of IOVA stock, worth $422,047. This represents 0.05% of its overall portfolio holdings.

Number of Shares

57,188

Previous 77,240 25.96%

Holding current value

$422,047

Previous $619,000 13.41%

% of portfolio

0.05%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$7.28 - $11.9 $145,978 - $238,618	-20,052 Reduced 25.96%	57,188 $536,000
Q2 2024 Aug 12, 2024	SELL	$7.78 - $14.19 $755,920 - $1.38 Million	-97,162 Reduced 55.71%	77,240 $619,000
Q1 2024 May 13, 2024	BUY	$7.59 - $17.47 $1.32 Million - $3.05 Million	174,402 New	174,402 $2.58 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $831,403 - $1.65 Million	187,253 Added 141.59%	319,502 $1.45 Million
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $393,022 - $664,324	73,325 Added 124.44%	132,249 $931,000
Q1 2023 May 12, 2023	SELL	$5.53 - $8.22 $837,662 - $1.25 Million	-151,476 Reduced 71.99%	58,924 $360,000
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $894,670 - $1.59 Million	159,194 Added 310.89%	210,400 $1.34 Million
Q3 2022 Nov 10, 2022	SELL	$9.53 - $13.11 $520,090 - $715,465	-54,574 Reduced 51.59%	51,206 $491,000
Q2 2022 Aug 04, 2022	BUY	$6.38 - $18.33 $544,813 - $1.57 Million	85,394 Added 418.89%	105,780 $1.17 Million
Q1 2022 May 11, 2022	BUY	$12.38 - $19.1 $252,378 - $389,372	20,386 New	20,386 $339,000
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $1.07 Million - $1.78 Million	-64,556 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $12,210 - $15,978	600 Added 0.94%	64,556 $1.59 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $1.04 Million - $2.12 Million	63,956 New	63,956 $1.66 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $260,766 - $341,111	-9,397 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$27.21 - $41.0 $255,692 - $385,277	9,397 New	9,397 $258,000
Q4 2018 Feb 14, 2019	SELL	$7.51 - $11.93 $207,276 - $329,268	-27,600 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$11.25 - $17.7 $310,500 - $488,520	27,600 New	27,600 $311,000

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.16B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account

Seven Eight Capital, LP Iovance Biotherapeutics, Inc. Transaction History